Professional
Added to YB: 2024-10-23
Pitch date: 2024-09-30
BAYN.DE [bullish]
Bayer Aktiengesellschaft
+49.9%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Market Cap
EUR 45.3B
Pitch Price
EUR 30.40
Price Target
N/A
Dividend
0.24%
EV/EBITDA
9.43
P/E
-228.86
EV/Sales
1.70
Sector
Pharmaceuticals
Category
special_situation
Show full summary:
Oakmark Global Strategy Portfolio Holding: Bayer Aktiengesellschaft
BAYN.DE: Stock up on favorable US RoundUp ruling. CFO update on DSO reorganization: 900+ teams, streamlining ops. Focus on cost & execution. Long-term shareholder benefit potential. Pharma, consumer health & crop science company.
Read full article (1 min)